Compare NAT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NAT | INSP |
|---|---|---|
| Founded | 1995 | 2007 |
| Country | Bermuda | United States |
| Employees | N/A | 1333 |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1997 | 2018 |
| Metric | NAT | INSP |
|---|---|---|
| Price | $5.42 | $44.06 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $4.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 2.9M | 1.2M |
| Earning Date | 05-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.50% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $77.72 | $8.02 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | $525.49 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $2.55 | $39.61 |
| 52 Week High | $6.34 | $147.66 |
| Indicator | NAT | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | 39.79 |
| Support Level | $5.39 | $39.61 |
| Resistance Level | $6.30 | $59.40 |
| Average True Range (ATR) | 0.19 | 2.62 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 16.34 | 50.00 |
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.